Clinical Disease Activity With Long Term Natalizumab Treatment

Clinical trial NCT02677077 · COMPLETED

Trial details

NCT number: NCT02677077
Sponsor: Biogen
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2015-12-31
Primary completion: 2016-08-18
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.